These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33319241)

  • 1. Genetic variations in microRNA-binding sites of solute carrier transporter genes as predictors of clinical outcome in colorectal cancer.
    Bendova P; Pardini B; Susova S; Rosendorf J; Levy M; Skrobanek P; Buchler T; Kral J; Liska V; Vodickova L; Landi S; Soucek P; Naccarati A; Vodicka P; Vymetalkova V
    Carcinogenesis; 2021 Apr; 42(3):378-394. PubMed ID: 33319241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in microRNA binding sites of mucin genes as predictors of clinical outcome in colorectal cancer patients.
    Vymetalkova V; Pardini B; Rosa F; Jiraskova K; Di Gaetano C; Bendova P; Levy M; Veskrnova V; Buchler T; Vodickova L; Naccarati A; Vodicka P
    Carcinogenesis; 2017 Jan; 38(1):28-39. PubMed ID: 27803053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-binding site polymorphisms in genes involved in colorectal cancer etiopathogenesis and their impact on disease prognosis.
    Schneiderova M; Naccarati A; Pardini B; Rosa F; Gaetano CD; Jiraskova K; Opattova A; Levy M; Veskrna K; Veskrnova V; Buchler T; Landi S; Vodicka P; Vymetalkova V
    Mutagenesis; 2017 Oct; 32(5):533-542. PubMed ID: 29048575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-strand break repair and colorectal cancer: gene variants within 3' UTRs and microRNAs binding as modulators of cancer risk and clinical outcome.
    Naccarati A; Rosa F; Vymetalkova V; Barone E; Jiraskova K; Di Gaetano C; Novotny J; Levy M; Vodickova L; Gemignani F; Buchler T; Landi S; Vodicka P; Pardini B
    Oncotarget; 2016 Apr; 7(17):23156-69. PubMed ID: 26735576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single nucleotide polymorphisms within MicroRNAs, MicroRNA targets, and MicroRNA biogenesis genes and their impact on colorectal cancer survival.
    Mullany LE; Herrick JS; Wolff RK; Slattery ML
    Genes Chromosomes Cancer; 2017 Apr; 56(4):285-295. PubMed ID: 27859935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of miRSNPs associated with the risk of multiple myeloma.
    Macauda A; Calvetti D; Maccari G; Hemminki K; Försti A; Goldschmidt H; Weinhold N; Houlston R; Andersen V; Vogel U; Buda G; Varkonyi J; Sureda A; Martinez Lopez J; Watek M; Butrym A; Sarasquete ME; Dudziński M; Jurczyszyn A; Druzd-Sitek A; Kruszewski M; Subocz E; Petrini M; Iskierka-Jażdżewska E; Raźny M; Szombath G; Marques H; Zawirska D; Chraniuk D; Halka J; Hove Jacobsen SE; Mazur G; García Sanz R; Dumontet C; Moreno V; Stępień A; Beider K; Pelosini M; Manuel Reis R; Krawczyk-Kulis M; Rymko M; Avet-Loiseau H; Lesueur F; Grząśko N; Ostrovsky O; Jamroziak K; Vangsted AJ; Jerez A; Tomczak W; Zaucha JM; Kadar K; Sainz J; Nagler A; Landi S; Gemignani F; Canzian F
    Int J Cancer; 2017 Feb; 140(3):526-534. PubMed ID: 27718532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in microRNA target sites modulate risk of lymphoblastic and myeloid leukemias and affect microRNA binding.
    Dzikiewicz-Krawczyk A; Macieja A; Mały E; Januszkiewicz-Lewandowska D; Mosor M; Fichna M; Strauss E; Nowak J
    J Hematol Oncol; 2014 Jun; 7():43. PubMed ID: 24886876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation within 3'-UTRs of base excision repair genes and response to therapy in colorectal cancer patients: A potential modulation of microRNAs binding.
    Pardini B; Rosa F; Barone E; Di Gaetano C; Slyskova J; Novotny J; Levy M; Garritano S; Vodickova L; Buchler T; Gemignani F; Landi S; Vodicka P; Naccarati A
    Clin Cancer Res; 2013 Nov; 19(21):6044-56. PubMed ID: 24036853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-binding site polymorphisms and risk of colorectal cancer: A systematic review and meta-analysis.
    Gholami M; Larijani B; Sharifi F; Hasani-Ranjbar S; Taslimi R; Bastami M; Atlasi R; Amoli MM
    Cancer Med; 2019 Dec; 8(17):7477-7499. PubMed ID: 31637880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variation in microRNA-binding site and prognosis of patients with colorectal cancer.
    Kim JG; Chae YS; Lee SJ; Kang BW; Park JY; Lee EJ; Jeon HS; Park JS; Choi GS
    J Cancer Res Clin Oncol; 2015 Jan; 141(1):35-41. PubMed ID: 25079514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Genetic Variation in MicroRNA-binding Site on Susceptibility to Colorectal Cancer.
    Kang BW; Jeon HS; Chae YS; Lee SJ; Park JS; Choi GS; Kim JG
    Anticancer Res; 2016 Jul; 36(7):3353-61. PubMed ID: 27354594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in Non-coding RNA Genes and Their Targets Sites as Risk Factors of Sporadic Colorectal Cancer.
    Vodicka P; Pardini B; Vymetalkova V; Naccarati A
    Adv Exp Med Biol; 2016; 937():123-49. PubMed ID: 27573898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA binding site polymorphism in inflammatory genes associated with colorectal cancer: literature review and bioinformatics analysis.
    Karimzadeh MR; Zarin M; Ehtesham N; Khosravi S; Soosanabadi M; Mosallaei M; Pourdavoud P
    Cancer Gene Ther; 2020 Nov; 27(10-11):739-753. PubMed ID: 32203060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer.
    Landi D; Gemignani F; Naccarati A; Pardini B; Vodicka P; Vodickova L; Novotny J; Försti A; Hemminki K; Canzian F; Landi S
    Carcinogenesis; 2008 Mar; 29(3):579-84. PubMed ID: 18192692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploiting a novel miR-519c-HuR-ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer.
    To KK; Leung WW; Ng SS
    Exp Cell Res; 2015 Nov; 338(2):222-31. PubMed ID: 26386386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
    To KK; Tong CW; Wu M; Cho WC
    World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The polymorphisms of miRNA-binding site in MLH3 and ERCC1 were linked to the risk of colorectal cancer in a case-control study.
    Zhang Q; Zheng X; Li X; Sun D; Xue P; Zhang G; Xiao M; Cai Y; Jin C; Yang J; Wu S; Lu X
    Cancer Med; 2018 Apr; 7(4):1264-1274. PubMed ID: 29516665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SNPs in microRNA-binding sites in the ITGB1 and ITGB3 3'-UTR increase colorectal cancer risk.
    Ye P; Li Z; Jiang H; Liu T
    Cell Biochem Biophys; 2014 Sep; 70(1):601-7. PubMed ID: 24777809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in miRNA-binding sites of nucleotide excision repair genes and colorectal cancer risk.
    Naccarati A; Pardini B; Stefano L; Landi D; Slyskova J; Novotny J; Levy M; Polakova V; Lipska L; Vodicka P
    Carcinogenesis; 2012 Jul; 33(7):1346-51. PubMed ID: 22581836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility.
    Nicoloso MS; Sun H; Spizzo R; Kim H; Wickramasinghe P; Shimizu M; Wojcik SE; Ferdin J; Kunej T; Xiao L; Manoukian S; Secreto G; Ravagnani F; Wang X; Radice P; Croce CM; Davuluri RV; Calin GA
    Cancer Res; 2010 Apr; 70(7):2789-98. PubMed ID: 20332227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.